-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Dk061W9sD1FBGTuEr/nfq5e6txBeqZ2JY1TFan0/yhX0Mlxb844+oKAf0MPW82W4 abScH6WeGnKrXPafqR4O7Q== 0000853285-02-000130.txt : 20020502 0000853285-02-000130.hdr.sgml : 20020501 ACCESSION NUMBER: 0000853285-02-000130 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUN LIFE OF CANADA U S VARIABLE ACCOUNT F CENTRAL INDEX KEY: 0000853285 IRS NUMBER: 042461439 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 333-82957 FILM NUMBER: 02631168 BUSINESS ADDRESS: STREET 1: 112 WORCESTER ST. CITY: WELLESLEY HILLS STATE: MA ZIP: 02481 BUSINESS PHONE: 7812636405 MAIL ADDRESS: STREET 1: 112 WORCESTER ST. CITY: WELLESLEY HILLS STATE: MA ZIP: 02481 497 1 accolade.htm SUPPLEMENT DATED __________, 2001

SUPPLEMENT DATED APRIL 30, 2002

TO

PROSPECTUS DATED APRIL 30, 2002

FOR

FUTURITY ACCOLADE NY VARIABLE AND FIXED ANNUITY

ISSUED BY SUN LIFE INSURANCE AND ANNUITY COMPANY OF NEW YORK

SUN LIFE (N.Y.) VARIABLE ACCOUNT C

Proposed Substitutions of Funds

On December 27, 2001, Sun Life Insurance and Annuity Company of New York ("the Company" or "Sun Life of New York ") filed an application with the Securities and Exchange Commission ("SEC") seeking an order approving the substitution of shares of certain investment portfolios of Alger American Fund ("Alger") currently held by Sun Life (N.Y.) Variable Account C ("Account C") for shares of certain investment portfolios of Sun Capital Advisers Trust ("Sun Capital"). To the extent required by law, approvals of such substitutions will also be obtained from the state insurance regulators in certain jurisdictions.

If such approvals are granted, the Alger American Growth Portfolio, Alger American Income & Growth Portfolio and Alger American Small Capitalization Portfolio will no longer be available investment options under your Contract.

Effect of the Substitutions

The effect of the substitutions would be to replace each of the Alger portfolios shown in Column I with the corresponding Sun Capital portfolio shown in Column II:

Column I (Replaced Funds)

Column II (Substitute Funds)

Alger American Growth Portfolio

SC Alger Growth Fund*

Alger American Income & Growth Portfolio

SC Alger Income & Growth Fund*

Alger American Small Capitalization Portfolio

SC Alger Small Capitalization Fund*

            *Available for investment on May 1, 2002.

The Replaced Funds have similar investment objectives to their respective Substitute Funds. Contract owners and prospective purchasers should carefully read the Sun Capital prospectus dated May 1, 2002.

The advisers to each of the Sun Capital Funds will also serve as subadvisers to the corresponding Substitute Funds. Sun Capital and its adviser, Sun Capital Advisers, Inc. ("SC Advisers") have received an exemptive order from the SEC permitting SC Advisers, subject to the approval of Sun Capital's board of trustees, to select subadvisers to serve as portfolio managers of the funds or to materially modify an existing subadvisory contract without obtaining shareholder approval of a new or amended subadvisory contract. SC Advisers has ultimate responsibility to oversee and to recommend the hiring, termination and replacement of any subadviser.

With respect to the Replaced Funds, the Company will not exercise any rights reserved under your Contract to impose restrictions or fees on transfers from the Replaced Funds or Substitute Funds until at least thirty (30) days after the proposed substitutions occur.

If the proposed substitutions are carried out, each Contract owner affected by the substitutions will be sent a written notice informing them that the substitutions were carried out.

The Replaced Funds will be closed for all future payments, allocations and transfers on May 1, 2002.

THIS SUPPLEMENT SHOULD BE READ AND RETAINED FOR FUTURE REFERENCE.

-----END PRIVACY-ENHANCED MESSAGE-----